abstract |
The present invention provides a novel fructosenresponsive transcription control cis-element and antranscriptional regulatory factor that interacts therewith, annon-human animal having them transferred or inactivated, andiagnostic method for genetic susceptibility to a metabolicndisorder using them, and a screening method for a prophylacticnor therapeutic drug for a metabolic disorder using them. |